Eon Mini neurostimulator is approximately the size of a matchbox and combines patient comfort with 10-year battery longevity ST. PAUL, Minn.–(HSMN NewsFeed)–St. Jude Clinical, Inc. (NYSE:STJ ) today announced Australian Therapeutic Goods Administration…
Devices, Regulatory
St. Jude Clinical, Eon Mini, neurostimulator
Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.
To get the details: Click Here
0 Comments on “St. Jude Pharma Receives Australian TGA Regulatory and Reimbursement Approval for the World’s Smallest and Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain”
Leave a Comment